StonvexLoading…
StonvexStonvexStonvexCore line items from EVMN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $0.00 | $13.00M | $13.00M | $3.00M |
Operating Income | $-23.95M | $-81.07M | $-51.35M | $-15.03M |
Net Income | $-21.67M | $-68.87M | $-40.60M | $-14.56M |
EPS (Diluted) | $-0.64 | $-11.22 | $-26.36 | $-9.48 |
Total Assets | $322.45M | $224.95M | $84.54M | Not available |
Total Liabilities | $17.90M | $19.38M | $10.68M | Not available |
Cash & Equivalents | $48.32M | $44.06M | $26.82M | $5.70M |
Free Cash Flow OCF − CapEx | $-27.59M | $-76.68M | $-59.87M | $-23.90M |
Shares Outstanding | 36.02M | 31.52M | 1.55M | 1.53M |